On April 1st 2025, Déborah Carlson Burkart (pictured) joined Eversheds Sutherland as the firm’s new Of-Counsel in Bern, moving from Wernli Rechtsanwälte. Burkart’s legal experience spans the areas of corporate law, corporate
Kellerhals Carrard advised Swiss clinical-stage biotechnology company MoonLake Immunotherapeutics on its agreement with American venture lending specialist Hercules Capital for up to $500 million in non-dilutive capital, with an initial $75 million drawn at closing. Pursuant to
Kellerhals Carrard advised Bloom Biorenewables in connection with the closing of its CHF 13M Series A financing round. The investors Anaïs Ventures and Valquest Partners led the capital round in question, with further participation
Advestra advised Banque Cantonale de Genève on its inaugural EUR-Bonds of EUR 500 million. The issuance Banque Cantonale de Genève debuted on the EUR-bonds market, issuing bonds in the aggregate prin
As of March 2025, Ferdinand Winter (pictured) has been appointed General Counsel of Ten23 health, a Swiss pharmaceutical contract development and manufacturing organization. Moving from Hansa Biopharma, Sweden, Ferdinand will be responsible for establishing and leading
CMS Switzerland advised Spanish hotel brand and lease management company Room Mate Hotels hotel on its acquisition – by way of a share deal – of the Geneva-based Hotel Marmont’s long leasehold. The context The 4-star
Niederer Kraft Frey (NKF) advised outpatient healthcare provider Affidea on the acquisition of Uroviva Group. Moreover, Advestra advised German Equity Partners IV, a fund managed by the independent German
Karen Hale (pictured) is the new Chief Legal and Compliance Officer for Novartis, effective April 14, 2025. Following the new appointment, Hale will continue to report to Vas Narasimhan, CEO of Novartis, and remain on the Executive
Lenz & Staehelin advised Vivalto Partners on Swiss tax matters in connection with its acquisition of Linnea, an international pharmaceutical manufacturer of botanical ingredients based in Switzerland. The context Headquartered in Paris, Vivalto Partners is